Katarzyna A Korzeniowska1, Michał Brzeziński2,3, Kamila Szarejko2, Marcin Radziwiłł2, Tomasz Anyszek2,4, Leszek Czupryniak2,5, Piotr Soszyński2,6, Per-Olof Berggren7, Malgorzata Mysliwiec8,2. 1. Department of Paediatrics, Diabetology, and Endocrinology, Medical University of Gdansk, Gdańsk, Poland. kkorzeniowska@gumed.edu.pl. 2. "PoZdro" Scientific Board, Medicover Foundation, Warsaw, Poland. 3. Department of Public Health and Social Medicine, Medical University of Gdansk, Gdansk, Poland. 4. Synevo Polska, Warsaw, Poland. 5. Department of Internal Diseases and Diabetology, Warsaw Medical University, Warsaw, Poland. 6. Medicover Sp. z.o.o., Warsaw, Poland. 7. Department of Molecular Medicine and Surgery, Karolinska Insitutet, Stockholm, Sweden. 8. Department of Paediatrics, Diabetology, and Endocrinology, Medical University of Gdansk, Gdańsk, Poland.
Abstract
INTRODUCTION: Obesity has increased rapidly among children and adolescents during the last 30 years. Paediatric patients with a BMI above the 85th centile are more often diagnosed with increased TSH levels than are children with proper body weight. MATERIAL AND METHODS: The data of 961 overweight and obese children, aged 13 years, recruited in four cities in Poland as part of PoZdro!, a two-year prophylactic program, were analysed to observe the relationship between serum TSH and fT4 concentration and carbohydrate and lipid metabolism parameters, as well as anthropometric parameters. RESULTS: TSH concentration in the study group was positively correlated, whereas fT4 concentration was negatively correlated with WHR and WHtR values, fasting serum glucose concentrations and one-hour glucose concentration, fasting serum insulin concentrations, one-hour and two-hour insulin concentration, ALT serum activity, as well as total cholesterol, LDL cholesterol, and triglyceride serum concentrations. An increased risk of metabolic syndrome was diagnosed previously in patients with TSH concentrations > 2.5 mUI/L. CONCLUSIONS: TSH concentration in the upper half of the current reference range (> 2.50 mIU/L) is associated with an increased risk of lipid and carbohydrate metabolism disorders and therefore increased chances of developing metabolic syndrome. It seems advisable to regularly monitor thyroid function in overweight and obese paediatric patients.
INTRODUCTION: Obesity has increased rapidly among children and adolescents during the last 30 years. Paediatric patients with a BMI above the 85th centile are more often diagnosed with increased TSH levels than are children with proper body weight. MATERIAL AND METHODS: The data of 961 overweight and obesechildren, aged 13 years, recruited in four cities in Poland as part of PoZdro!, a two-year prophylactic program, were analysed to observe the relationship between serum TSH and fT4 concentration and carbohydrate and lipid metabolism parameters, as well as anthropometric parameters. RESULTS:TSH concentration in the study group was positively correlated, whereas fT4 concentration was negatively correlated with WHR and WHtR values, fasting serum glucose concentrations and one-hour glucose concentration, fasting serum insulin concentrations, one-hour and two-hour insulin concentration, ALT serum activity, as well as total cholesterol, LDL cholesterol, and triglyceride serum concentrations. An increased risk of metabolic syndrome was diagnosed previously in patients with TSH concentrations > 2.5 mUI/L. CONCLUSIONS:TSH concentration in the upper half of the current reference range (> 2.50 mIU/L) is associated with an increased risk of lipid and carbohydratemetabolism disorders and therefore increased chances of developing metabolic syndrome. It seems advisable to regularly monitor thyroid function in overweight and obese paediatric patients.
Authors: Katarzyna Adamczewska; Zbigniew Adamczewski; Andrzej Lewiński; Renata Stawerska Journal: Front Endocrinol (Lausanne) Date: 2022-03-24 Impact factor: 5.555
Authors: Oscar H Roa Dueñas; Anna C Van der Burgh; Till Ittermann; Symen Ligthart; M Arfan Ikram; Robin Peeters; Layal Chaker Journal: J Clin Endocrinol Metab Date: 2022-05-17 Impact factor: 6.134